BridgeBio Pharma Inc.

05/13/2022 | Press release | Distributed by Public on 05/13/2022 05:31

BridgeBio Pharma Sells Rare Pediatric Disease Priority Review Voucher for $110 Million and Defers Principal Payment on Senior Debt by Two Years